Short-Term Growth During Treatment with Inhaled Fluticasone Propionate/Formoterol, Fluticasone and Beclomethasone Treatment

Journal of Aerosol Medicine and Pulmonary Drug Delivery
O D WolthersSanjeeva Dissanayake

Abstract

Fluticasone propionate/formoterol (FP/FORM) is a pressurized metered-dose inhaler (pMDI; Flutiform®) approved for use in adolescents and adults and under development for pediatric use. To compare short-term growth in asthmatic children treated with FP/FORM, FP pMDI with valved holding chamber, and beclomethasone dipropionate (BDP) in a breath-actuated device. Children with persistent asthma (n = 48; 5 to <12 years) participated in an assessor-blinded, randomized, three-way crossover trial with run in, wash out, and active treatment periods, each of 2 weeks duration. Interventions were FP/FORM 100/10 μg b.i.d. with an AeroChamber Plus® Flow-Vu® Spacer, FP pMDI (Flixotide®) 100 μg b.i.d. with a Volumatic® spacer, and extra-fine BDP breath-actuated inhaler (Aerobec®/QVAR® Autohaler®) 100 μg b.i.d. Lower leg growth rate (LLGR) was measured by knemometry. The least square (LS) mean difference in LLGR between FP/FORM and FP (per protocol population) was -0.006 mm/week (95% CI: -0.095 to 0.084; p < 0.001 for noninferiority [noninferiority margin -0.200 mm/week]). Both treatments elicited no change from baseline off-treatment growth rate. The LS mean treatment difference of FP/FORM versus BDP was 0.116 mm/week (95% CI: -0.004 to 0.235;...Continue Reading

References

Jul 20, 1991·BMJ : British Medical Journal·O D Wolthers, S Pedersen
Aug 31, 2002·Respiratory Medicine·A WoodcockG Poli
Jun 12, 2003·The European Respiratory Journal·S G DevadasonP N Le Souëf
Nov 24, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·O D Wolthers
Mar 27, 2009·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Lone Agertoft, Søren Pedersen
May 9, 2009·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·O D Wolthers
Jan 18, 2011·European Journal of Clinical Pharmacology·Arun NairBrian J Lipworth
Sep 4, 2012·The New England Journal of Medicine·H William KellyUNKNOWN CAMP Research Group
Jan 13, 2015·Respiratory Medicine·Alberto PapiSanjeeva Dissanayake
Sep 12, 2015·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Ole D Wolthers

❮ Previous
Next ❯

Citations

Dec 20, 2017·Clinical Drug Investigation·Ole D WolthersSanjeeva Dissanayake
Jan 31, 2018·Therapeutic Advances in Respiratory Disease·Sanjeeva Dissanayake, Jason Suggett
May 21, 2021·Clinical Chemistry and Laboratory Medicine : CCLM·Ole D WolthersAnne Vibeke Schmedes

❮ Previous
Next ❯

Software Mentioned

SAS
Autohaler
Aerobec Autohaler

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.